Real-World Comparison of Overall Survival in Female Patients with HR+/HER2- Metastatic breast cancer receiving endocrine therapy, endocrine therapy plus palbociclib, or chemotherapy
{"title":"Real-World Comparison of Overall Survival in Female Patients with HR+/HER2- Metastatic breast cancer receiving endocrine therapy, endocrine therapy plus palbociclib, or chemotherapy","authors":"U. Rizwan, R. Hussain, G. Kanagala","doi":"10.1016/j.ejca.2024.113714","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":505596,"journal":{"name":"European Journal of Cancer","volume":"114 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.ejca.2024.113714","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
